Cargando…

Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size

MDCO-216 is a complex of dimeric ApoA-IMilano and palmitoyl oleoyl phosphatidylcholine (POPC), previously shown to reduce atherosclerotic plaque burden. Here we studied the effect of incubation of human plasma or serum with MDCO-216 on cholesterol efflux capacity from J774 cells, on prebeta-1 high d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kempen, Herman J., Schranz, Dorota B., Asztalos, Bela F., Otvos, James, Jeyarajah, Elias, Drazul-Schrader, Denise, Collins, Heidi L., Adelman, Steven J., Wijngaard, Peter L. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244927/
https://www.ncbi.nlm.nih.gov/pubmed/25478232
http://dx.doi.org/10.1155/2014/923903
_version_ 1782346289930829824
author Kempen, Herman J.
Schranz, Dorota B.
Asztalos, Bela F.
Otvos, James
Jeyarajah, Elias
Drazul-Schrader, Denise
Collins, Heidi L.
Adelman, Steven J.
Wijngaard, Peter L. J.
author_facet Kempen, Herman J.
Schranz, Dorota B.
Asztalos, Bela F.
Otvos, James
Jeyarajah, Elias
Drazul-Schrader, Denise
Collins, Heidi L.
Adelman, Steven J.
Wijngaard, Peter L. J.
author_sort Kempen, Herman J.
collection PubMed
description MDCO-216 is a complex of dimeric ApoA-IMilano and palmitoyl oleoyl phosphatidylcholine (POPC), previously shown to reduce atherosclerotic plaque burden. Here we studied the effect of incubation of human plasma or serum with MDCO-216 on cholesterol efflux capacity from J774 cells, on prebeta-1 high density lipoprotein (prebeta-1 HDL) and on HDL size assessed by proton nuclear magnetic resonance ((1)H-NMR). MDCO-216 incubated in buffer containing 4% human serum albumin stimulated both ABCA1-mediated efflux and ABCA1-independent cholesterol efflux from J774 macrophages. When incubated with human serum a dose- and time-dependent synergistic increase of the ABCA1-mediated efflux capacity were observed. Using a commercially available ELISA for prebeta-1 HDL, MDCO-216 as such was poorly detected (12–15% of nominal amount of protein). Prebeta-1 HDL was rapidly lost when human plasma alone is incubated at 37°C. In contrast, incubation of human plasma with MDCO-216 at 37°C produced a large amount of new prebeta-1 HDL. Native 2D electrophoresis followed by immunoblotting with an apoA-I antibody, which also detects ApoA-I Milano, confirmed the increase in prebeta-1 HDL upon incubation at 37°C. With the increase of prebeta-1 HDL, the concomitant disappearance of the small alpha-3 and alpha-4 HDL and MDCO-216 and an increase in the large alpha-1 and alpha-2 HDL were observed. Immunoblotting with Mab 17F3 specific for ApoA-I Milano showed the appearance of ApoA-I Milano in alpha-1 and alpha-2, but not in prebeta-1 HDL. (1)H-NMR analysis of plasma incubated with MDCO-216 confirmed rapid disappearance of small-sized HDL particles and increase of medium- and large-sized HDL particles accompanied with a decrease in total HDL particle number. In conclusion, incubation of human plasma or serum with MDCO-216 strongly enhanced ABCA1-mediated cholesterol efflux, caused a strong increase of prebeta-1 HDL, and drastically changed the distribution of HDL subpopulations. Overall, the results are in line with the hypothesis that MDCO-216 fuses with small alpha-migrating HDL particles forming larger particles containing both apoA-I WT and ApoA-I Milano, meanwhile liberating the endogenous wild-type apoA-I which enriches prebeta-1 HDL subpopulation.
format Online
Article
Text
id pubmed-4244927
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-42449272014-12-04 Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size Kempen, Herman J. Schranz, Dorota B. Asztalos, Bela F. Otvos, James Jeyarajah, Elias Drazul-Schrader, Denise Collins, Heidi L. Adelman, Steven J. Wijngaard, Peter L. J. J Lipids Research Article MDCO-216 is a complex of dimeric ApoA-IMilano and palmitoyl oleoyl phosphatidylcholine (POPC), previously shown to reduce atherosclerotic plaque burden. Here we studied the effect of incubation of human plasma or serum with MDCO-216 on cholesterol efflux capacity from J774 cells, on prebeta-1 high density lipoprotein (prebeta-1 HDL) and on HDL size assessed by proton nuclear magnetic resonance ((1)H-NMR). MDCO-216 incubated in buffer containing 4% human serum albumin stimulated both ABCA1-mediated efflux and ABCA1-independent cholesterol efflux from J774 macrophages. When incubated with human serum a dose- and time-dependent synergistic increase of the ABCA1-mediated efflux capacity were observed. Using a commercially available ELISA for prebeta-1 HDL, MDCO-216 as such was poorly detected (12–15% of nominal amount of protein). Prebeta-1 HDL was rapidly lost when human plasma alone is incubated at 37°C. In contrast, incubation of human plasma with MDCO-216 at 37°C produced a large amount of new prebeta-1 HDL. Native 2D electrophoresis followed by immunoblotting with an apoA-I antibody, which also detects ApoA-I Milano, confirmed the increase in prebeta-1 HDL upon incubation at 37°C. With the increase of prebeta-1 HDL, the concomitant disappearance of the small alpha-3 and alpha-4 HDL and MDCO-216 and an increase in the large alpha-1 and alpha-2 HDL were observed. Immunoblotting with Mab 17F3 specific for ApoA-I Milano showed the appearance of ApoA-I Milano in alpha-1 and alpha-2, but not in prebeta-1 HDL. (1)H-NMR analysis of plasma incubated with MDCO-216 confirmed rapid disappearance of small-sized HDL particles and increase of medium- and large-sized HDL particles accompanied with a decrease in total HDL particle number. In conclusion, incubation of human plasma or serum with MDCO-216 strongly enhanced ABCA1-mediated cholesterol efflux, caused a strong increase of prebeta-1 HDL, and drastically changed the distribution of HDL subpopulations. Overall, the results are in line with the hypothesis that MDCO-216 fuses with small alpha-migrating HDL particles forming larger particles containing both apoA-I WT and ApoA-I Milano, meanwhile liberating the endogenous wild-type apoA-I which enriches prebeta-1 HDL subpopulation. Hindawi Publishing Corporation 2014 2014-11-12 /pmc/articles/PMC4244927/ /pubmed/25478232 http://dx.doi.org/10.1155/2014/923903 Text en Copyright © 2014 Herman J. Kempen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kempen, Herman J.
Schranz, Dorota B.
Asztalos, Bela F.
Otvos, James
Jeyarajah, Elias
Drazul-Schrader, Denise
Collins, Heidi L.
Adelman, Steven J.
Wijngaard, Peter L. J.
Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size
title Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size
title_full Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size
title_fullStr Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size
title_full_unstemmed Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size
title_short Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size
title_sort incubation of mdco-216 (apoa-imilano/popc) with human serum potentiates abca1-mediated cholesterol efflux capacity, generates new prebeta-1 hdl, and causes an increase in hdl size
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244927/
https://www.ncbi.nlm.nih.gov/pubmed/25478232
http://dx.doi.org/10.1155/2014/923903
work_keys_str_mv AT kempenhermanj incubationofmdco216apoaimilanopopcwithhumanserumpotentiatesabca1mediatedcholesteroleffluxcapacitygeneratesnewprebeta1hdlandcausesanincreaseinhdlsize
AT schranzdorotab incubationofmdco216apoaimilanopopcwithhumanserumpotentiatesabca1mediatedcholesteroleffluxcapacitygeneratesnewprebeta1hdlandcausesanincreaseinhdlsize
AT asztalosbelaf incubationofmdco216apoaimilanopopcwithhumanserumpotentiatesabca1mediatedcholesteroleffluxcapacitygeneratesnewprebeta1hdlandcausesanincreaseinhdlsize
AT otvosjames incubationofmdco216apoaimilanopopcwithhumanserumpotentiatesabca1mediatedcholesteroleffluxcapacitygeneratesnewprebeta1hdlandcausesanincreaseinhdlsize
AT jeyarajahelias incubationofmdco216apoaimilanopopcwithhumanserumpotentiatesabca1mediatedcholesteroleffluxcapacitygeneratesnewprebeta1hdlandcausesanincreaseinhdlsize
AT drazulschraderdenise incubationofmdco216apoaimilanopopcwithhumanserumpotentiatesabca1mediatedcholesteroleffluxcapacitygeneratesnewprebeta1hdlandcausesanincreaseinhdlsize
AT collinsheidil incubationofmdco216apoaimilanopopcwithhumanserumpotentiatesabca1mediatedcholesteroleffluxcapacitygeneratesnewprebeta1hdlandcausesanincreaseinhdlsize
AT adelmanstevenj incubationofmdco216apoaimilanopopcwithhumanserumpotentiatesabca1mediatedcholesteroleffluxcapacitygeneratesnewprebeta1hdlandcausesanincreaseinhdlsize
AT wijngaardpeterlj incubationofmdco216apoaimilanopopcwithhumanserumpotentiatesabca1mediatedcholesteroleffluxcapacitygeneratesnewprebeta1hdlandcausesanincreaseinhdlsize